XT
RGC icon

XTX Topco’s Regencell Bioscience RGC Stock Holding History

XTX Topco’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+60,061
New +$1.44M ﹤0.01% 2738
2026
Q1 		– Sell
-15,081
Closed -$317K – 4289
2025
Q4 		$317K Sell
15,081
-23,654
-61% -$385K 0.01% 2018
2025
Q3 		$598K Buy
+38,735
New +$556K 0.03% 936

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

XTX Topco's RGC Position: Q2 2026 in Review

XTX Topco opened a new position in Regencell Bioscience (RGC) in Q2 2026: 60,061 shares worth $366K. The stake represents ﹤0.01% of the portfolio and ranks #2738 among its holdings. This is a return to the name: XTX Topco previously reported a position in RGC as recently as Q4 2025.

XTX Topco first reported a position in RGC in Q3 2025 and has held it in 3 quarters since. The position peaked at $598K in Q3 2025. 35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • XTX Topco held 60,061 shares of Regencell Bioscience worth $366K as of Q2 2026.
  • Regencell Bioscience was a new XTX Topco position in Q2 2026.
  • Regencell Bioscience made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2738 holding.
  • XTX Topco first reported a position in Regencell Bioscience in Q3 2025 and has held it in 3 quarters since.
  • XTX Topco's Regencell Bioscience position peaked at $598K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.